Salix Pharmaceuticals, Ltd. engages in the acquisition, development, and commercialization of prescription drugs used in the treatment of various gastrointestinal diseases in the United States. Its products include Colazal capsules for the treatment of ulcerative colitis; Xifaxan, which is a gastrointestinal-specific oral antibiotic for the treatment of travelers’ diarrhea caused by noninvasive strains of E coli in patients of 12 years of age and above; Visicol tablets and OsmoPrep tablets for cleansing the bowel as a preparation for colonoscopy; and Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and...
read more
SLXP, Salix Pharmaceuticals, Ltd.
** On its third quarter fiscal 2011 results, SLXP posted total product revenue of $146.2 million, an 81% increase year over year.
SLXP is increasing its estimate of 2011 total product revenue to approximately $535 million, which represents 59% growth over 2010 revenue.
SLXP develops and markets prescription pharmaceutical products for the prevention and treatment of gastrointestinal read more
National Health Partners, Inc. (NHPR.OB) is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that read more
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
